A detailed history of Neos Investment Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Neos Investment Management LLC holds 26,996 shares of INCY stock, worth $2.08 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
26,996
Previous 26,867 0.48%
Holding current value
$2.08 Million
Previous $1.63 Billion 9.56%
% of portfolio
0.05%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$57.33 - $68.61 $7,395 - $8,850
129 Added 0.48%
26,996 $1.78 Billion
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $823,281 - $1.03 Million
16,086 Added 149.21%
26,867 $1.63 Billion
Q1 2024

May 13, 2024

BUY
$56.55 - $66.59 $63,279 - $74,514
1,119 Added 11.58%
10,781 $614 Million
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $300,285 - $369,541
5,757 Added 147.43%
9,662 $607 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $225,591 - $257,456
3,905 New
3,905 $226 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.